New rices may help address vitamin A and iron deficiency, major causes of death in the developing world

    Genetically modified grain able to improve supply of iron and vitamin A in human diet -- lack of these nutrients is a major contributor to maternal and childhood death, disease and blindness in developing countries

St. Louis, MO, August 3, 1999 -- Researchers announced today that they have genetically modified rice grains to improve the supply of iron and vitamin A in the human diet. The genetically modified rices may help to reduce global rates of iron deficiency anemia (IDA) and vitamin A deficiency (VAD), especially in developing countries where the major staple food is rice. IDA and VAD are major contributors to childhood and maternal mortality and morbidity primarily in developing countries.

The research results were announced by Professor Ingo Potrykus at the XVI International Botanical Congress where more than 4,000 scientists from 100 countries are meeting to discuss the latest results of research on plants for human survival and improved quality of life. Professor Potrykus is a researcher with the Swiss Federal Institute of Technology's Institute for Plant Sciences. Professor Potrykus was the principal investigator for the two separate research teams conducting the vitamin A and iron research. The Rockefeller Foundation supported Professor Potrykus's vitamin A research.

IDA, the most common nutritional disorder in the world, impairs immunity and reduces the physical and mental capacities of people of all ages. In infants and young children, even mild anemia can impair intellectual development. Anemia in pregnancy is an important cause of maternal mortality, increasing the risk of hemorrhage and sepsis during childbirth. Infants born to anemic mothers often suffer from low birth weight and anemia themselves. An inadequate dietary intake of iron is the main cause of IDA.

According to UNICEF, nearly 2 billion people are estimated to be anemic and about double that number, or 3.7 billion, are iron deficient, the v

Contact: Ellen Wilson, Dennis Kelly, or Eileen Kugler
XVI International Botanical Congress

Page: 1 2 3 4

Related biology news :

1. Deregulation will cause significant fluctuations in electricity prices, new study reveals
2. National nanotech expert to address UW-Madison conference
3. Rimonbant shows promise in addressing multiple risk factors
4. Worlds largest-ever sea turtle symposium to address plummeting populations of sea turtles
5. Parasites enzyme structure helps address a public health issue
6. Briefing to address what women dont know about lung cancer
7. Whalley picked for keynote address at The Gerontological Society of Americas 2003 Annual Meeting
8. New vaccines may address need to protect newborns in the developing world
9. Immerge BioTherapeutics announces new findings addressing key safety risk in xenotransplantation
10. Scientists at Scripps Research Institute address mysteries of ozone in the human body
11. Life sciences publishers take steps to address potential misuse of information by bioterrorists

Post Your Comments:

(Date:9/30/2019)... ... September 30, 2019 , ... Foresight Institute, a ... other transformative technologies, announced the winners for the 2019 Foresight Institute Feynman Prizes. ... Theory in nanotechnology/molecular manufacturing. , Established in 1993 and named in honor of ...
(Date:9/30/2019)... DURHAM, N.C. (PRWEB) , ... September 30, 2019 , ... ... therapy and an accepted model for studying the development and diseases of the human ... or potential activities of the progeny heart muscle cells to be clearly and easily ...
(Date:9/30/2019)... ALTO, Calif. (PRWEB) , ... ... ... Institute, a leading think tank, research, and public interest organization focused on ... prestigious Distinguished Student Prize. , The Award recognizes the College graduate or ...
Breaking Biology News(10 mins):
(Date:10/10/2019)... ... 10, 2019 , ... VirTrial today announced an ... Europe. All Pratia research centers have completed VirTrial’s Virtual Trial Capable training, making ... Virtual Trial Capable and prepared to conduct decentralized clinical trials (DCT). , The ...
(Date:10/8/2019)... ... October 07, 2019 , ... Erchonia ... therapy technology (“3LT®”), today announces that the U.S. Food and Drug Administration (FDA) ... laser for the temporary relief of chronic neck and shoulder pain of musculoskeletal ...
(Date:10/3/2019)... ... 01, 2019 , ... Today Cereset®, the only proven non-invasive ... of its randomized research trial for individuals with persisting symptoms following mild-Traumatic Brain ... a non-invasive technology which compares tones delivered to a subject’s brain guided by ...
(Date:10/3/2019)... ... October 02, 2019 , ... ... leadership firm that is enabling clinical program outsourcing success by cultivating radical improvements ... pharma and biotech veteran executive Brenda Reese, phaseUP™ brings clients deep, broad and ...
Breaking Biology Technology:
Cached News: